- Home
- NKTX vs VOR Comparison
NKTX vs VOR Comparison
Compare NKTX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- VOR
- Stock Information
- Founded
- NKTX 2015
- VOR 2015
- Country
- NKTX United States
- VOR United States
- Employees
- NKTX N/A
- VOR N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- NKTX Health Care
- VOR Health Care
- Exchange
- NKTX Nasdaq
- VOR Nasdaq
- Market Cap
- NKTX 170.8M
- VOR 161.9M
- IPO Year
- NKTX 2020
- VOR 2021
- Fundamental
- Price
- NKTX $2.05
- VOR $1.37
- Analyst Decision
- NKTX Strong Buy
- VOR Strong Buy
- Analyst Count
- NKTX 5
- VOR 7
- Target Price
- NKTX $15.20
- VOR $11.36
- AVG Volume (30 Days)
- NKTX 853.6K
- VOR 419.2K
- Earning Date
- NKTX 03-20-2025
- VOR 03-19-2025
- Dividend Yield
- NKTX N/A
- VOR N/A
- EPS Growth
- NKTX N/A
- VOR N/A
- EPS
- NKTX N/A
- VOR N/A
- Revenue
- NKTX N/A
- VOR N/A
- Revenue This Year
- NKTX N/A
- VOR N/A
- Revenue Next Year
- NKTX N/A
- VOR N/A
- P/E Ratio
- NKTX N/A
- VOR N/A
- Revenue Growth
- NKTX N/A
- VOR N/A
- 52 Week Low
- NKTX $1.96
- VOR $0.63
- 52 Week High
- NKTX $16.24
- VOR $2.43
- Technical
- Relative Strength Index (RSI)
- NKTX 39.74
- VOR 50.68
- Support Level
- NKTX $1.96
- VOR $1.36
- Resistance Level
- NKTX $2.35
- VOR $1.50
- Average True Range (ATR)
- NKTX 0.15
- VOR 0.11
- MACD
- NKTX -0.00
- VOR -0.01
- Stochastic Oscillator
- NKTX 19.15
- VOR 37.50
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.